risk of surgery is very low in healthy individuals
goal of the preop evaluation is to identify and quantify any comorbidities that may affect the
operative outcome
the goal is not to screen for undiagnosed disease
Age
minor component of preoperative coronary risk after multivariate analysis
independent risk factor for postoperative pulmonary complications
much of the risk associated with age is due to increasing numbers of comorbidities
(cognitive impairment, functional impairment, malnutrition, frailty)
Exercise Capacity
important determinant of overall perioperative risk
no cardiac evaluation is necessary if the patient can expend ≥ 4 METS
(climb up 2 flights of stairs, walk up a hill, heavy housework, walk at 4 mph at ground
level)
Medications
provides insight into patients’ medical condition – diabetes, hypertension, CAD, etc
must specifically ask about ASA, Plavix, NSAIDs, beta-blockers, anticoagulants
Nutritional Status
weight loss > 10% over 6 months or 5% in a month is significant
temporal wasting, cachexia, ascites, peripheral edema may corroborate the history
however, obesity is not protective of malnutrition – it is possible for overweight patients
to have micro- and macronutrient deficiencies
albumin, transferrin, and prealbumin have historically been used to support a diagnosis of malnutrition,
but they are not considered to be adequate in isolation
if necessary, a registered dietician can be consulted for a complete nutritional assessment
Obesity
BMI > 40 is associated with increased perioperative mortality
often associated with other comorbid conditions: hypertension, CHF, ischemic heart disease,
sleep apnea
is an independent risk factor for pulmonary embolism/DVT
also associated with increased wound infections
Obstructive Sleep Apnea (OSA)
increases risk of cardiac arrest, hypoxemia, respiratory failure, reintubation, and ICU transfer
most patients with OSA are undiagnosed
consider screening at-risk patients for OSA before surgery
Alcohol Abuse
associated with increased post op complications (wound infections, other infections,
cardiopulmonary complications
must identify any underlying liver disease
withdrawal can be a major issue
optimal period of cessation is unknown (? 4 weeks)
Drug Use
chronic opioid use is associated with tolerance, which can make pain control difficult
drug withdrawal is also a major issue
pain management specialists may need to be involved in the patient's perioperative care
Smoking
associated with increased complications – poor wound healing, wound infections,
pneumonia, respiratory failure, and cardiovascular events
smoking cessation ≥ 6 weeks before surgery may reduce the risk of postoperative complications
Family History
bleeding problems
complications from anesthesia – malignant hyperthermia
Laboratory Evaluation
routine preoperative testing is not indicated in the absence of clinical indications
false-positive results lead to unnecessary follow up tests, increased costs and risks, as well as
delay in surgery
selective testing is appropriate in patients with known underlying diseases or risk factors that
would affect operative management
CBC
anemia is rare (1%) in asymptomatic patients
however, preop anemia predicts postop mortality
data is unclear if the anemia is the risk factor, or if it is a marker of risk
baseline Hg measurement is recommended for patients ≥ 65 who are undergoing major
surgery
also recommended in younger patients undergoing surgery that may result in significant blood
loss
Renal Function
mild to moderate renal dysfunction is asymptomatic and prevalent with increasing age
creatinine > 2.0 is one of 6 independent risk factors that predict postoperative cardiac
complications
renal insufficiency also necessitates drug dosage adjustments
appropriate to obtain serum creatinine level in patients > 50 undergoing intermediate or
high risk procedures
Electrolytes
frequency of unsuspected electrolyte abnormalities is < 1%
routine electrolyte measurements are not necessary unless the history suggests their
presence (renal disease, diuretic use)
Blood Glucose
insulin-dependent diabetes is a risk factor for postop cardiac complications
no evidence that asymptomatic hyperglycemia, in a patient not known to have diabetes,
increases surgical risk
routine measurement of serum glucose is not necessary in healthy patients
Liver Function Tests
significant liver disease is suggested by the history
mild elevations of LFTs in patients with no known liver disease is not associated with
increased morbidity/mortality
routine LFTs are not indicated
PT/PTT
history, physical exam, and family history should suggest the presence of a bleeding
disorder
not routinely indicated
Urinalysis
goal is to detect unsuspected UTIs or renal insufficiency
unclear whether treating an asymptomatic UTI decreases rates of wound infection
may be of value in patients undergoing prosthetic joint replacements
Pregnancy Testing
mandatory in all women of reproductive age
pregnancy alters surgical management and decision making, especially in elective cases
EKGs
not indicated in asymptomatic patients undergoing low-risk procedures
can be considered in asymptomatic patients undergoing riskier procedures
(cardiac risk ≥ 1%)
Chest X-Rays
only necessary if there is a history of cardiopulmonary disease
abnormal findings are common, and result in additional tests and costs that do not benefit
the patient
Risk Factors Most Predictive of Postoperative Mortality
National Surgical Quality Improvement Program (NSQIP)
has been used to develop predictive models for post-op morbidity/mortality
ASA 4/5 is associated with the largest odds ratio (8:1)
ASA 3 (3.5:1), DNR (3.9:1), disseminated cancer (2.9:1), emergency procedure (2.6:1) are also
significant independent predictors of postoperative complications
Evaluation of Cardiac Risk
Incidence
among unselected patients > 40 years old, perioperative MI occurs in 1.4% and cardiac death in 1%
among patients with some selection criteria, perioperative MI occurs in 3.2% and cardiac death in
1.7%
Mechanism
surgery predisposes to myocardial ischemia: blood loss, volume shifts, increased myocardial oxygen
consumption from heart rate and BP elevations
patients with underlying cardiac and peripheral vascular disease have high incidences of coronary
artery disease and low ejection fractions
Preoperative Evaluation
History
symptoms: angina, dyspnea, syncope, palpitations
history: hypertension, diabetes, kidney disease, cerebrovascular or peripheral vascular
disease
functional status: inability to climb 2 flights of stairs or walk 4 blocks is associated
with increased cardiac complications
Physical Exam
BP measurement, auscultation of the heart and lungs, abdominal palpation, examine
extremities for edema and pulses
important findings include evidence of CHF or a murmur
EKG
should be obtained in all patients with cardiovascular disease, unless it is a low-risk
procedure
should be evaluated for Q waves, ST-segment changes, arrhythmias, bundle branch blocks, etc
Surgery Specific Risk
High Risk Procedures
risk of cardiac death or nonfatal MI > 5%
aortic or major vascular surgery
Intermediate Risk Procedures
risk of cardiac death or nonfatal MI 1-5%
laparotomies, thoracotomies, major urologic or orthopedic procedures
Low Risk Procedures
cardiac complication rate < 1%
day surgery procedures: hernias, breast biopsies, endoscopies
Estimating Perioperative Risk
patient-specific risk factors, combined with surgery specific risk factors, are used to estimate
the risk of adverse postoperative cardiac events
Goldman Cardiac Risk Index was first devised in 1977
Revised Cardiac Risk Index was developed in 1999, and uses 6 easily obtained predictors of
complications to estimate cardiac risk in noncardiac surgical patients
predictors were developed through multivariate analysis
each independent predictor is worth one point
points are then added together to yield a total, which has been correlated with operative risk
Management Based on Risk
low risk patients (<1%) require no additional testing
higher risk patients may require additional cardiac testing
Additional Cardiac Testing
additional testing should only be done if it is indicated in the absence of the proposed surgery
“preop” is not a valid reason for additional testing
Stress Testing
used to diagnose obstructive coronary artery disease
strong relationship between extent of myocardial ischemia and prognosis
however, there is no evidence that prophylactic revascularization improves outcomes
Echocardiography
used to evaluate left ventricular systolic function and valvular heart disease, which are
associated with postoperative heart failure
24-hour Monitoring
used primarily for patients with syncope or arrhythmias
Cardiac Interventions
Revascularization
goal of risk assessment is to determine if any cardiac intervention will reduce the risk of
a post-op cardiac event
CABG vs angioplasty vs stenting
bare metal stents require a minimum of 1 month of dual antiplatelet therapy
drug-eluting stents require a minimum of 6 months of dual antiplatelet therapy
ideally, all elective procedures should de deferred for one year after stent placement
wait 4 – 6 weeks after an MI before performing elective surgery
Medical Therapy
beta blockers are the most studied drugs
purpose is to decrease the adrenergic surge after surgery and halt platelet activation and
microvascular thrombosis
in 1996, a study was published that showed a large decrease in post-op cardiac complications
in medium – high risk patients receiving beta blockers in the perioperative period
in 2007, another study (POISE) showed the potential harm of perioperative beta blockers
POISE study confirmed the reduction in post-op cardiac morbidity/mortality
however, these gains were negated by an increased stroke and total mortality rate
current recommendations for beta blockers: 1) continue them in patients taking them
preoperatively; 2) consider them for high-risk patients; 3) don’t give them to low-risk
patients
specific risks: COPD, asthma, pneumonia, smoking, sleep apnea, dyspnea
Pulmonary Function Testing
indications: lung resections, single lung ventilation cases, major abdominal surgery with
significant pulmonary symptoms
tests: FEV1, forced vital capacity, diffusing capacity of carbon monoxide
patients with FEV1 < 30% of predicted (0.8 Liter/sec) have high risk of post-op pulmonary
insufficiency
Preoperative Interventions
goal is to reduce post-op complications
bronchodilator therapy, steroids for asthmatic patients, antibiotics for pneumonia
? smoking cessation
exercise – walking 3 miles several times/week
consider spinal or epidural anesthesia where appropriate
Renal Evaluation
Pre-op Considerations
pre-op creatinine > 2.0 is an independent risk factor for cardiac complications
renal patients usually have coexisting cardiac, metabolic, endocrine problems
patients may be volume overloaded
anemia is common
qualitative platelet dysfunction
Pre-op Interventions
erythropoietin to correct anemia if an elective case
correction of volume status
calcium replacement for hypocalcemia
phosphate binders for hyperphosphatemia
correction of hyperkalemia
dialysis may be necessary to correct volume and electrolyte abnormalities
Post-Operative Management
avoid nephrotoxic drugs
use renal dosing
strict attention to volume status
Hepatic Evaluation
Child-Pugh Scoring System
stratifies operative risk in cirrhotic patients
Child A mortality = 10%; Child B, 31%; Child C 76% for abdominal operations
Model for End-Stage Liver Disease (MELD)
another commonly used risk stratification tool
uses a formula based on bilirubin, creatinine, INR
Umbilical Hernia Repair in Cirrhotics
may rupture if tense ascites is present, with increased mortality rates
preoperatively, need to reduce ascites to a minimum with aggressive diuretic therapy
mortality rate may be as high as 14%
Cholecystectomy in Cirrhotic Patients
consider non-operative management since mortality is high
when surgery is necessary, lap choly is associated with less bleeding than open choly
Diabetes
Perioperative Diabetic Management
pre-op goal is to identify diabetic complications that will affect the patient’s perioperative
management (cardiac disease, PVD, renal dysfunction)
hemoglobin A1c > 8% is associated with postoperative infectious complications such as wound
infection, pneumonia, and sepsis
Perioperative Medical Management
withhold oral agents on the morning of surgery; resume once able to take PO
rapid and short-acting insulins are held once patient is NPO
intermediate and long-acting insulins are given as two-thirds the normal evening dose the night
before surgery, and one-half the morning dose the day of surgery
frequent bedside glucose determinations
hyperglycemia is treated with short-acting insulins
5% dextrose infusion should be started the morning of surgery
Steroid Replacement
Determine if Patient has Adrenal Suppression
patients who have taken > 20 mg prednisone for > 3 weeks are presumed to have adrenal suppression
patients who have taken 5 – 20 mg prednisone for > 3 weeks in the past year are considered to be at
risk for adrenal suppression
low doses of steroids or minor procedures are not associated with adrenal suppression
if unclear, low-dose ACTH stimulation test to determine suppression can be done
Steroid Replacement
titrate replacement dose to degree of surgical stress
moderate stress operations (cholecystectomy): 50 mg IV hydrocortisone before induction; 25 mg
IV q 8 hr for 24 – 48 hrs; then resume usual dose
major stress operations (colectomy): 100 mg IV hydrocortisone before induction; 50 mg IV q 8 hrs for
24 – 48 hrs; then resume usual dose
References
UpToDate, Preoperative Medical Evaluation of the Healthy Patient. August 10, 2015. Pgs 1 – 19.
UpToDate, Evaluation of Cardiac Risk Prior to Noncardiac Surgery. December 30, 2014. Pgs 1 – 15.